Laheurte, Caroline
Dosset, Magalie
Vernerey, Dewi
Boullerot, Laura
Gaugler, Béatrice
Gravelin, Eléonore
Kaulek, Vincent
Jacquin, Marion
Cuche, Laurie
Eberst, Guillaume
Jacoulet, Pascale
Fabre, Elizabeth
Le Pimpec-Barthes, Françoise
Tartour, Eric
De Carvalho Bittencourt, Marcelo
Westeel, Virginie
Adotévi, Olivier
Article History
Received: 20 January 2019
Revised: 25 June 2019
Accepted: 3 July 2019
First Online: 30 July 2019
Competing interests
: The authors declare no competing interests.
: All patients and healthy donors gave their signed informed consent, and the protocol was approved by local ethic committees and the French national drug agency (Comité de Protection des Personnes CPP Ile de France IV, 2009/17NICB, N°EUDRACT: 2009-A00642-55). The study was conducted in accordance with the Declaration of Helsinki.
: This work was supported by grants from Assistance Publique Hopitaux de Paris, La Ligue Contre le Cancer, the Conseil Regional de Franche-Comte, Canceropole Grand Est.
: All authors consent the material to publish.
: The data sets generated during and/or analysed during this study are available from the corresponding author on reasonable request.